ProKidney Net Interest Income from 2010 to 2026
| PROK Stock | USD 2.23 0.03 1.33% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 22.7 M | Current Value 23.8 M | Quarterly Volatility 9.5 M |
Check ProKidney Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProKidney Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 M, Interest Expense of 9.8 K or Selling General Administrative of 34.9 M, as well as many indicators such as Price To Sales Ratio of 1.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 9.4 K. ProKidney financial statements analysis is a perfect complement when working with ProKidney Corp Valuation or Volatility modules.
ProKidney | Net Interest Income | Build AI portfolio with ProKidney Stock |
Historical Net Interest Income data for ProKidney Corp serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether ProKidney Corp represents a compelling investment opportunity.
Latest ProKidney Corp's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of ProKidney Corp over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. ProKidney Corp's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ProKidney Corp's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
ProKidney Net Interest Income Regression Statistics
| Arithmetic Mean | 5,513,184 | |
| Geometric Mean | 207,386 | |
| Coefficient Of Variation | 172.04 | |
| Mean Deviation | 7,727,436 | |
| Median | 43,000 | |
| Standard Deviation | 9,484,743 | |
| Sample Variance | 90T | |
| Range | 23.8M | |
| R-Value | 0.78 | |
| Mean Square Error | 38T | |
| R-Squared | 0.60 | |
| Significance | 0.0002 | |
| Slope | 1,460,136 | |
| Total Sum of Squares | 1439.4T |
ProKidney Net Interest Income History
About ProKidney Corp Financial Statements
ProKidney Corp investors utilize fundamental indicators, such as Net Interest Income, to predict how ProKidney Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 22.7 M | 23.8 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of ProKidney Corp Correlation against competitors. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. Anticipated expansion of ProKidney directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ProKidney Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate ProKidney Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ProKidney Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause ProKidney Corp's market price to deviate significantly from intrinsic value.
It's important to distinguish between ProKidney Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProKidney Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, ProKidney Corp's market price signifies the transaction level at which participants voluntarily complete trades.